Authors:
Piret, J
Gagne, N
Perron, S
Desormeaux, A
Tremblay, MJ
Gourde, P
Omar, RF
Bergeron, MG
Citation: J. Piret et al., Thermoreversible gel as a candidate barrier to prevent the transmission ofHIV-1 and herpes simplex virus type 2, SEX TRA DIS, 28(8), 2001, pp. 484-491
Authors:
Proulx, ME
Desormeaux, A
Marquis, JF
Olivier, M
Bergeron, MG
Citation: Me. Proulx et al., Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin, ANTIM AG CH, 45(9), 2001, pp. 2623-2627
Citation: J. Bestman-smith et al., Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment, ANTIM AG CH, 45(8), 2001, pp. 2229-2237
Authors:
Roy, S
Gourde, P
Piret, J
Desormeaux, A
Lamontagne, J
Haineault, C
Omar, RF
Bergeron, MG
Citation: S. Roy et al., Thermoreversible gel formulations containing sodium lauryl sulfate or n-lauroylsarcosine as potential topical microbicides against sexually transmitted diseases, ANTIM AG CH, 45(6), 2001, pp. 1671-1681
Authors:
Piret, J
Lamontagne, J
Desormeaux, A
Bergeron, MG
Citation: J. Piret et al., Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1, ANTIM AG CH, 45(4), 2001, pp. 1030-1036
Authors:
Bestman-Smith, J
Desormeaux, A
Tremblay, MJ
Bergeron, MG
Citation: J. Bestman-smith et al., Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B, AIDS, 14(16), 2000, pp. 2457-2465
Authors:
Piret, J
Lamontagne, J
Bestman-Smith, J
Roy, S
Gourde, P
Desormeaux, A
Omar, RF
Juhasz, J
Bergeron, MG
Citation: J. Piret et al., In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses, J CLIN MICR, 38(1), 2000, pp. 110-119
Authors:
Piret, J
Desormeaux, A
Cormier, H
Lamontagne, J
Gourde, P
Juhasz, J
Bergeron, MG
Citation: J. Piret et al., Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice, ANTIM AG CH, 44(9), 2000, pp. 2263-2270
Authors:
Piret, J
Desormeaux, A
Gourde, P
Juhasz, J
Bergeron, MG
Citation: J. Piret et al., Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection, ANTIM AG CH, 44(1), 2000, pp. 30-38
Authors:
Bestman-Smith, J
Gourde, P
Desormeaux, A
Tremblay, MJ
Bergeron, MG
Citation: J. Bestman-smith et al., Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1, BBA-BIOMEMB, 1468(1-2), 2000, pp. 161-174
Authors:
Morin, NJ
Delorme, C
Gourde, P
Omar, RF
Desormeaux, A
Tremblay, MJ
Beauchamp, D
Rousseau, A
Bergeron, MG
Citation: Nj. Morin et al., Reducing chorioretinal viral counts with intravitreal foscarnet injectionsin a rabbit model of Herpes simplex virus type-1 retinitis, J OCUL PH T, 15(5), 1999, pp. 465-477
Authors:
Piret, J
Gourde, P
Cormier, H
Desormeaux, A
Beauchamp, D
Tremblay, MJ
Juhasz, J
Bergeron, M
Citation: J. Piret et al., Efficacy of gel formulations containing free and liposomal foscarnet in a murine model of cutaneous HSV-1 infection, J LIPOS RES, 9(2), 1999, pp. 181-198